Clinical Trial

Prenatal and Postnatal Ultrasonographic Evaluation of Myelomeningocele to Predict Post-Surgical Outcomes

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 2, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Myelomeningocele (MMC), also known as open spina bifida, is a serious congenital condition in which the cord and meninges protrude through the spinal column's defective bony encasement due to a defective closure of the posterior portion of the neural tube between the fourth week of pregnancy.
Trial Details
NCT Number NCT07048691
Lead Sponsor Superior University
Conditions Myelomeningocele
Enrollment 20 participants
Start Date 2025-03-17
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-07-02